Advertisement
Home Tags Gene Therapy

Tag: Gene Therapy

Gene Therapy Beneficial for Patients With Hemophilia B

One infusion of etranacogene dezaparvovec noninferior and superior to factor IX prophylaxis

FDA Approves First Cell-Based Gene Therapy for Beta-Thalassemia

The single-dose treatment is approved for transfusion-dependent adults and children

Gene Therapy Promising for SCID Due to ADA Deficiency

High overall, event-free survival seen at 24 and 36 months for severe combined immunodeficiency due to ADA deficiency

Trial of Gene Therapy for Sickle Cell Disease Halted

Two patients participating in the study developed cancer years after treatment

Breyanzi Approved for Certain Types of Large B-Cell Lymphoma

The CAR T cell therapy OK'd for patients who have not responded to or have relapsed after receiving two or more other systemic treatments

A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia

Medicare to Cover CAR-T Therapy for Leukemia, Lymphoma

Chimeric antigen receptor T-cell therapy boosts a patient's own immune cells
The maker of Zolgensma (onasemnogene abeparvovec-xioi) gave manipulated data to the U.S. Food and Drug Administration when it approved the drug

FDA: Approval of Zolgensma Was Based on Manipulated Data

Despite inaccurate data, FDA says it is 'confident that Zolgensma should remain on the market'
Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.

Lifesaving Drug for Infants Costs $2.1 Million a Dose

When Zolgensma was approved, maker Novartis said it expected insurance companies to cover the cost
The first gene therapy has been approved to treat children younger than 2 years with spinal muscular atrophy

FDA Approves First Gene Therapy for Spinal Muscular Atrophy

Patients treated with Zolgensma have shown improvement in reaching developmental motor milestones
For patients with Parkinson's disease undergoing gene therapy

Gene Therapy Forms New Polysynaptic Pathways in Parkinson’s

Patients receiving GAD gene therapy develop unique treatment-dependent polysynaptic brain circuit